AdamsD. D., PurvesH. D. (1956). Abnormal responses in the assay of thyrotropin. Proceedings University Otago Medical School, 34, 11
2.
AdamsD. D., KennedyT. H., PurvesH. D. (1969). Comparison of the thyroid-stimulating hormone content of serum from thyrotoxic and euthyroid people. Journal of Clinical Endocrinology, 29, 900
3.
AlexanderW. D., HardenR. McG., ShimminsJ. (1966). Thyroidal suppression by triiodothyronine as a guide to the duration of treatment of thyrotoxicosis with antithyroid drugs. Lancet, 2, 1041
4.
AlexanderW. D., HardenR. McG., ShimminsJ., McLartyD., McGillP. (1967). Treatment of thyrotoxicosis based on thyroidal suppressibility. Lancet, 2, 681
5.
AstwoodE. B. (1967). Use of antithyroid drugs. In Thyrotoxicosis, Proceedings of Symposium, Edinburgh, p. 85. Edited by IrvineW. J.Edinburgh: E. & S. Livingstone
6.
BelingU., EinhornJ. (1961). Incidence of hypothyroidism and recurrences following 131I treatment of hyperthyroidism. Acta Radiologica, 56, 275
7.
BoyleI. T., GreigW. R., ThomsonJ. A., WinningJ., McGirrE. M. (1969). Effects of thyroid ablation on dysthyroid exophthalmos. Proceedings, Royal Society of Medicine, 62, 13
8.
British Medical Journal (1961). Editorial. Potassium perchlorate and aplastic anaemia. British Medical Journal, 1, 1520
9.
British Medical Journal (1970). Editorial. Protean symptomatology of myxoedema. British Medical Journal, 2, 61
10.
BurkeG. (1967). Hyperthyroidism and demonstration of circulating long acting thyroid stimulator following hypophysectomy for chromophobe adenoma. Journal of Clinical Endocrinology, 27, 1161
11.
BurkeG., MonteJ., LevinsonI., ZitmanH. (1967). Thyroid carcinoma ten years after sodium iodide 131I treatment. Journal of American Medical Association, 199, 247
BurrellC. D. (1956). Fatal aplastic anaemia after treatment with carbimazole. British Medical Journal, 1, 1456
14.
CanaryJ. J., SchaafM., DuffyB. J.Jnr., KyleL. H. (1957). Effects of oral and intramuscular administration of reserpine in thyrotoxicosis. New England Journal of Medicine, 257, 435
15.
CarneiroL., DerringtonK. J., MonroD. S. (1966). Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immuno-globulin G. Clinical Science, 31, 215
16.
ChopraI. J., SolomonD. H. (1970). Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy and high serum L.A.T.S. Annals of Internal Medicine, 73, 985
17.
ColcockB. P. (1962). Primary hyperthyroidism: Results of surgical treatment. Surgical Clinics of North America, 42, 673
18.
CrooksJ., WayneE. J. (1960). A comparison of potassium perchlorate, methylthiouracil, and carbimazole in the treatment of thyrotoxicosis. Lancet, 1, 401
19.
CrooksJ., BuchananW. W., WayneE. J., McDonaldE. (1960). Effect of pretreatment with methylthiouracil on results of 131I therapy. British Medical Journal, 1, 151
20.
DasG., KreigerM. (1969). Treatment of thyrotoxic storm with intravenous administration of propranolol. Annals of Internal Medicine, 70, 985
21.
DillonP. T., BabeJ., MeloniC. R., CanaryJ. J. (1970). Reserpine in thyrotoxic crisis. New England Journal of Medicine, 283, 1020
22.
DuffyB. J., FitzgeraldP. J. (1950). Report on 28 cases of thyroid cancer in childhood and adolescence. Cancer, 3, 1018
23.
DunnJ. T., ChapmanE. M. (1964). Rising incidence of hypothyroidism after radioactive iodine therapy in thyrotoxicosis. New England Journal of Medicine, 271, 1037
24.
FrancoJ., CopplerM., KovaleskiB. (1970). Propranolol and 131I in the treatment of diffuse thyroid hyperplasia with hyperthyroidism. Journal of Nuclear Medicine, 11, 219
25.
FurthE. D., BeckerD. V., RayB. S., KaneJ. W. (1962). Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy. Journal of Clinical Endocrinology, 22, 518
26.
GillespieF. C., OrrJ. S., GreigW. R. (1970). Microscopic dose distribution from 125I in the toxic thyroid gland and its relation to therapy. British Journal of Radiology, 43, 40
27.
GooldenA. W. G. (1958). Carcinoma of the thyroid following irradiation. British Medical Journal, 2, 954
28.
GooldenA. W. G., FraserT. R. (1969). Treatment of thyrotoxicosis with low doses of radioactive iodine. British Medical Journal, 2, 442
29.
GouldE. A., HirschE., BrecherI. (1965). Complications arising in the course of thyroidectomy. Archives of Surgery, 90, 81
30.
GreenM., WilsonG. M. (1964). Thyrotoxicosis treated by surgery or iodine 131I with special reference to the development of hypothyroidism. British Medical Journal, 1, 1005
31.
GreeneR. (1951). The significance of lymphadenoid changes in the thyroid gland. Journal of Endocrinology, 7, 1
32.
GreeneR., MorganD. C. (1956). Toxicity of the antithyroid drug carbimazole. Journal of Clinical Endocrinology, 16, 391
33.
GreigW. R. (1965). Radiation, thyroid cells and 131I therapy—an hypothesis. Journal of Clinical Endocrinology, 25, 1411
34.
GreigW. R., SmithJ. F. B., GillespieF. C., ThomsonJ. A., McGirrE. M. (1969). Iodine-125 treatment for thyrotoxicosis. Lancet, 1, 755
35.
GreigW. R., GrayH. W., SmithJ. F. B., McDougallI. R., GillespieF. C., ThomsonJ. A., McGirrE. M. (1971). Treatment of thyrotoxicosis with iodine-125. Proceedings of Sixth International Thyroid Conference. Vienna, 1970. In press
36.
HaddenD. R., MontgomeryD. A. D., ShanksR. G., WeaverJ. A. (1968). Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet, 2, 852
37.
HagenG. A., OuelletteP., ChapmanE. M. (1967). Comparison of high and low dosage levels of 131I in the treatment of thyrotoxicosis. New England Journal of Medicine, 277, 559
38.
HallR., FordJ., MansonN. (1967). Ophthalmic Graves' disease. In Thyrotoxicosis, Proceedings of Symposium, Edinburgh, p. 210. Edited by IrvineW. J.Edinburgh: E. & S. Livingstone
39.
HallR. (1970). Hyperthyroidism—pathogenesis and diagnosis. British Medical Journal, 1, 743
40.
HamburgerJ. I., PaulS. (1968). When and how to use higher 131I doses for hyperthyroidism. New England Journal of Medicine, 279, 1361
41.
HamiltonC. R., AdamsL. C., MaloofF. (1970). Hyperthyroidism due to thyrotropin producing pituitary chromophobe adenoma. New England Journal of Medicine, 283, 1077
42.
HardenR. McG., ChisholmC. J., CantJ. S. (1967). The effect of metronidazole on thyroid function and exophthalmos in man. Metabolism, 16, 890
43.
HavardC. W. H. (1969). The aetiology and management of thyrotoxicosis. Abstracts of World Medicine, 43, 629
44.
HaweP. (1965). The management of thyrotoxicosis during pregnancy. British Journal of Surgery, 52, 731
45.
HaylesA. B., KennedyR. L. J., BeahrsO. H., WoolnerL. B. (1959). Exophthalmic goitre in children. Journal of Clinical Endocrinology, 19, 138
46.
HedleyA. J., FlemingC. J., ChesterM. I., MichieW., CrooksJ. (1970). Surgical treatment of thyrotoxicosis. British Medical Journal, 1, 519
47.
HermannH. T., QuartonG. G. (1965). Psychological changes and psychogenesis in thyroid hormone disorders. Journal of Clinical Endocrinology, 25, 327
48.
HershmanJ. M. (1966). The treatment of hyperthyroidism. Annals of Internal Medicine, 64, 1306
49.
HershmanJ. M., GivensJ. R., CassidyC. E., AstwoodE. B. (1966). Long-term outcome of hyperthyroidism treated with drugs. Journal of Clinical Endocrinology, 26, 803
50.
HetzelB. S. (1968). The aetiology and pathogenesis of hyperthyroidism. Postgraduate Medical Journal, 44,363
51.
HobsonQ. J. G. (1961). Aplastic anaemia due to treatment with potassium perchlorate. British Medical Journal, 1, 1368
52.
HowardJ. E. (1968). Treatment of thyrotoxicosis. Journal of American Medical Association, 202, 706
53.
IngbarS. H., WoebarK. A. (1968). The thyroid gland. In Williams Textbook of Endocrinology, 4th edition. Edited by WilliamsR. H.Philadelphia: W. B. Saunders Co. Ltd
54.
IrvineW. J., StewartA. G. (1967). Prognostic significance of thyroid antibodies in the management of thyrotoxicosis. In Thyrotoxicosis, Proceedings of Symposium, Edinburgh, p. 111. Edited by IrvineW. J.Edinburgh: E. & S. Livingstone
55.
JailerJ. W., HolubD. A. (1960). Remission of Graves' disease following radiotherapy of a pituitary neoplasm. American Journal of Medicine, 28, 497
56.
JohnsonR. S., MooreW. G. (1961). Fatal aplastic anaemia after treatment of thyrotoxicosis with potassium perchlorate. British Medical Journal, 1, 1369
57.
JonesK. H., FourmanP. (1963). Prevalence of parathyroid insufficiency after thyroidectomy. Lancet, 2, 121
58.
KaipainenW. J., VuopalaU., SalokannelJ., TakkunehJ., TimonenT. (1970). Low dose radioactive iodine in the treatment of hyperthyroidism. Annals of Clinical Research, 2, 122
59.
KarlanM. S., PollockS. F., SnyderW. H. (1964). Carcinoma of thyroid following treatment of hyperthyroidism with radioactive iodine. California Medicine, 101, 196
60.
KempersR. D., DockertyM. B., HoffmanD. L., BartholomewL. G. (1970). Struma ovarii—ascitic, hyperthyroid and asymptomatic symptoms. Annals of Internal Medicine, 72, 883
61.
KilpatrickR., BlomfieldG. W., NealF. E., WilsonG. M. (1957). Carcinoma of thyroid (review of 100 cases). Quarterly Journal of Medicine, 26, 209
62.
KrevansJ. R., AsperS. P.Jnr., RienhoffW. F.Jnr. (1961). Fatal aplastic anaemia following use of potassium perchlorate in thyrotoxicosis. Journal of American Medical Association, 181, 162
63.
KrissJ. P., PleshakovV., ChienJ. R. (1964). Isolation and identification of long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed myxoedema. Journal of Clinical Endocrinology, 24, 1005
LewitusZ., LubinE., RechnicJ., Ben-PorathM.FeigeY., LaorJ. (1970). Treatment of thyrotoxicosis with small doses of 125I. Abstract, p. 83. Sixth International Thyroid Conference, Vienna, 1970
66.
LimaJ. B., CatzB., PerzikS. L. (1970). Thyroid cancer following 131I therapy of hyperthyroidism. Journal of Nuclear Medicine, 11, 46
67.
LowryR. C., LoweD., HaddenD. R., MontgomeryD. A. D., WeaverJ. A. (1971). Thyroid suppressibility; follow-up for two years after antithyroid treatment. British Medical Journal, 2, 19
68.
McCullaghE. P., ReynoldsC. W., McKenzieJ. M. (1960). Hyperthyroidism after section of the pituitary stalk for malignant exophthalmos. Report of a case. Journal of Clinical Endocrinology, 20, 1029
69.
McDougallI. R., GreigW. R., GrayH. W., GillespieF. C. (1970). Iodine-125 treatment for thyrotoxicosis. Lancet, 2, 840
70.
McDougallI. R., GreigW. R. (1971). Combined carbimazole 131I therapy for thyrotoxicosis. Scottish Medical Journal, In press
71.
McDougallI. R., GreigW. R., GrayH. W., SmithJ. F. B. (1971a). Thyrotoxicosis developing during cyclophosphamide therapy. British Medical Journal, 4, 275
72.
McDougallI. R., ThomsonJ. A., KennedyJ. S. (1971b). Thyroid carcinoma following iodine-131 therapy. To be published, Journal of Clinical Endocrinology, 33, 287
73.
McGirrE. M., ThomsonJ. A., MurrayI. P. C. (1964). Radioiodine therapy in thyrotoxicosis. A review of 908 cases. Scottish Medical Journal, 9, 505
74.
McGirrE. M., GreigW. R. (1968). The treatment of thyrotoxicosis. Practitioner, 200, 485
75.
McKenzieJ. M. (1964). Neonatal Graves' disease. Journal of Clinical Endocrinology, 24, 660
76.
McNeillA. D., ThomsonJ. A. (1968). Long term follow-up of surgically treated thyrotoxic patients. British Medical Journal, 3, 643
77.
New England Journal of Medicine (1967). Editorial. A new look at radioiodine therapy of thyrotoxicosis. New England Journal of Medicine, 277, 596
78.
NofalM. M., BeierwaltesW. H., PatnoM. E. (1966). Treatment of hyperthyroidism with sodium iodide 131I. A 16 year experience. Journal of American Medical Association, 197, 605
79.
OchiY., de GrootL. J. (1968). Long acting thyroid stimulator of Graves' disease. New England Journal of Medicine, 278, 718
80.
OdellW. D., BatesR. W., RivlinR. S., LipsettM. B., HertyR. (1963). Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. Journal of Clinical Endocrinology, 23, 658
81.
OlsenW. R., NishiyamaR. H., GraberL. W. (1970). Thyroidectomy for hyperthyroidism. Archives of Surgery, 101, 175
82.
PainterN. S. (1960). The results of surgery in the treatment of toxic goitre. British Journal of Surgery, 48, 291
83.
PhilpJ. R., HarrisonM.T., RidleyE. F., CrooksJ. (1968). Treatment of thyrotoxicosis with ionising radiation. Lancet, 2, 1307
84.
PlestedW. G., PollockW. F. (1967). Radioactive iodine, antithyroid drugs and surgery in treatment of hyperthyroidism. Archives of Surgery, 94, 517
85.
PlummerH. F. (1923). The results of administering iodine to patients having exophthalmic goitre. Journal of American Medical Association, 80, 1955
86.
PochinE. E. (1960). Leukaemia following radioiodine treatment of thyrotoxicosis. British Medical Journal, 2, 1514
87.
RiddellV. (1965). The selection of patients for thyroidectomy. British Journal of Surgery, 52, 721
88.
RiddellV. (1970). Thyroidectomy: Prevention of bilateral recurrent nerve palsy. British Journal of Surgery, 57, 1
89.
RiddleM. C., SchwartzT. B. (1970). New tactics for hyperthyroidism: Sympatholytic drugs. Annals of Internal Medicine, 72, 749
90.
RoseE., SandersT. P., WebbW. L., HinesR. C. (1969). Occult factitial thyrotoxicosis; thyroxine kinetics and psychological evaluation in three cases. Annals of Internal Medicine, 71, 309
91.
RoyA. D., AllanJ., HardenR. McG. (1967). A follow-up of thyrotoxic patients treated by partial thyroidectomy. Lancet, 2, 684
92.
SaengerE. L., ThomaG. E., TompkinsE. A. (1968). Incidence of leukaemia following treatment of hyperthyroidism. Journal of American Medical Association, 205, 855
93.
ShelineG. E., LindsayS., BellH. G. (1959). Occurrence of thyroid nodules in children following therapy with radioiodine for hyperthyroidism. Journal of Clinical Endocrinology, 19, 127
94.
SmithR. N., WilsonG. M. (1967). Clinical trials of different doses of 131I in treatment of thyrotoxicos isBritish Medical Journal, 1, 129
95.
SnyderN. J., GreenD. C., SolomonD. H. (1964). Glucocorticoid-induced disappearance of long-acting thyroid stimulator in the ophthalmopathy of Graves' disease. Journal of Clinical Endocrinology. 24, 1129
96.
StaffurthJ. S. (1966). Thyroid cancer after 131I therapy for thyrotoxicosis. British Journal of Radiology, 39, 471
97.
StamlerF. W., LiechtyR. D., de GowinE. L. (1970). Metastasizing thyroid cancer ten years after radioactive treatment for hyperthyroidism. Journal of Iowa Medical Society, 60, 16
98.
SteinO., GrossJ. (1964). Metabolism of 125I in the thyroid gland studied with electron microscopic autoradiography. Endocrinology, 75, 787
99.
SterlingK., RefetoffS., SelenkowH. A. (1970). T3 thyrotoxicosis: Thyrotoxicosis due to elevated serum triiodothyronine levels. Journal of American Medical Association, 213, 571
100.
SterlingK. (1971). The importance of circulating triiodothyronine. New England Journal of Medicine, 284, 271
101.
VikerkoskiM., LambergB.-A., HembergC. A., NiemiE. (1971). Treatment of toxic nodular and diffuse goitre with radioactive iodine. Acta Endocrinologica, 64, 159
102.
VinikA. I., PimstoneB. L., HoffengergR. (1968). Sympathetic blockade in hyperthyroidism. Journal of Clinical Endocrinology, 28, 725
103.
VolpeR., Desbarats-SchonbaumM.-L., SchonbaumE., RowV. V., EzrinC. (1969). The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (L.A.T.S.). American Journal of Medicine, 46, 217
104.
WadeJ. S. H. (1965). Three major complications of thyroidectomy. British Journal of Surgery, 52, 727
105.
WahnerH. W., GormanC. A. (1971). Interpretation of serum triiodothyronine levels measured by the Sterling technic. New England Journal of Medicine284, 225
106.
WayneE. J. (1960). Clinical and metabolic studies in thyroid disease. British Medical Journal, 1, 78
107.
WayneE. J., KoutrasD. A., AlexanderW. D. (1964). Clinical aspects of iodine metabolism. Oxford: Blackwell Scientific Publications
108.
WeinerL., StoutB. D., CoxJ. W. (1969). Influence of beta-sympathetic blockade (propranolol) on the haemodynamics of hyperthyroidism. American Journal of Medicine, 46, 227
109.
WernerS. C. (1955). A new and simple test for hyperthyroidism employing triiodothyronine and the 24 hour 131I uptake method. Bulletin New York Academy of Medicine, 31, 137
110.
WernerS. C. (1966). Prednisone in emergency treatment of malignant exophthalmos. Lancet, 1, 1004
111.
WernerS. C. (1967). Immunosuppression in the management of the active severe eye changes of Graves' disease. In Thyrotoxicosis, Proceedings of Symposium, Edinburgh, p. 238. Edited by IrvineW. J.Edinburgh: E. & S. Livingstone
112.
WernerS. C., PlatmanS. R. (1965). Remission of hyperthyroidism (Graves' disease) and altered pattern of serum thyroxine binding induced by prednisone. Lancet, 2, 751
113.
WernerS. C., JohnsonP. M., GoodwinP. N., WeinerJ. D., LindeboomG. A. (1970). Long-term results with iodine-125 treatment for toxic diffiuse goitre. Lancet, 2, 681
114.
WillisJ. (1959). Thyroid carcinoma after irradiation in adult life. British Medical Journal, 2, 550
115.
WilsJ. A., KloppenborgP. W. C. (1970). Recurrence of hyperthyroidism shortly after return of normal suppressibility by triiodothyronine. British Medical Journal, 3, 327
116.
WilsonG. M. (1967). The treatment of thyrotoxicosis. In Symposium, Thyroid Disease and Calcium Metabolism, p. 51. Edinburgh: Royal College of Physicians